LEVO THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 7, 2021, a trademark application was filed for LEVO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LEVO THERAPEUTICS trademark a serial number of 90628691. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Sunday, October 6, 2024. This trademark is owned by Levo Therapeutics, Inc.. The LEVO THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
levo therapeutics

General Information

Serial Number90628691
Word MarkLEVO THERAPEUTICS
Filing DateWednesday, April 7, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateSunday, October 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLevo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077
Party NameLevo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077

Trademark Events

Event DateEvent Description
Saturday, April 10, 2021NEW APPLICATION ENTERED
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 23, 2021ASSIGNED TO EXAMINER
Sunday, November 28, 2021NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION WRITTEN
Sunday, November 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 28, 2021NON-FINAL ACTION WRITTEN
Thursday, January 6, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 6, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, January 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 6, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, January 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 9, 2022SOU EXTENSION 1 FILED
Friday, September 9, 2022SOU EXTENSION 1 GRANTED
Tuesday, September 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 15, 2023SOU EXTENSION 2 FILED
Wednesday, March 15, 2023SOU EXTENSION 2 GRANTED
Friday, March 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 11, 2023SOU EXTENSION 3 FILED
Monday, September 11, 2023SOU EXTENSION 3 GRANTED
Monday, March 18, 2024SOU EXTENSION 4 GRANTED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2024SOU EXTENSION 4 FILED
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, October 6, 2024SOU TEAS EXTENSION RECEIVED
Sunday, October 6, 2024SOU EXTENSION 5 FILED
Sunday, October 6, 2024SOU EXTENSION 5 GRANTED

Related Keywords

therapeutics levo pharmaceutical disorders treatment products preparations neurodevelopmental metabolic willi prader syndrome